296 related articles for article (PubMed ID: 15526164)
41. The ataxia telangiectasia-mutated and Rad3-related protein is dispensable for retroviral integration.
Dehart JL; Andersen JL; Zimmerman ES; Ardon O; An DS; Blackett J; Kim B; Planelles V
J Virol; 2005 Feb; 79(3):1389-96. PubMed ID: 15650165
[TBL] [Abstract][Full Text] [Related]
42. Gene delivery by retroviruses.
Deregowski V; Canalis E
Methods Mol Biol; 2008; 455():157-62. PubMed ID: 18463818
[TBL] [Abstract][Full Text] [Related]
43. Retroviral vectors for liver-directed gene therapy.
Kalpana GV
Semin Liver Dis; 1999; 19(1):27-37. PubMed ID: 10349681
[TBL] [Abstract][Full Text] [Related]
44. Retroviral vectors as insertional mutagens.
Gäken J; Farzaneh F
Methods Mol Biol; 1992; 8():111-30. PubMed ID: 21390706
[TBL] [Abstract][Full Text] [Related]
45. The genome of Moloney murine leukemia virus can be integrated by the integrase of human immunodeficiency virus type 1 expressed alone in vivo.
Peng WJ; Pan JT; Lai MC; Chiu CF; Lin TH
Proc Natl Sci Counc Repub China B; 1997 Oct; 21(4):144-60. PubMed ID: 9369024
[TBL] [Abstract][Full Text] [Related]
46. Vector integration is nonrandom and clustered and influences the fate of lymphopoiesis in SCID-X1 gene therapy.
Deichmann A; Hacein-Bey-Abina S; Schmidt M; Garrigue A; Brugman MH; Hu J; Glimm H; Gyapay G; Prum B; Fraser CC; Fischer N; Schwarzwaelder K; Siegler ML; de Ridder D; Pike-Overzet K; Howe SJ; Thrasher AJ; Wagemaker G; Abel U; Staal FJ; Delabesse E; Villeval JL; Aronow B; Hue C; Prinz C; Wissler M; Klanke C; Weissenbach J; Alexander I; Fischer A; von Kalle C; Cavazzana-Calvo M
J Clin Invest; 2007 Aug; 117(8):2225-32. PubMed ID: 17671652
[TBL] [Abstract][Full Text] [Related]
47. Retrovirus insertion into herpesviruses.
Isfort RJ; Witter R; Kung HJ
Trends Microbiol; 1994 May; 2(5):174-7. PubMed ID: 8055182
[TBL] [Abstract][Full Text] [Related]
48. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1.
Hacein-Bey-Abina S; Von Kalle C; Schmidt M; McCormack MP; Wulffraat N; Leboulch P; Lim A; Osborne CS; Pawliuk R; Morillon E; Sorensen R; Forster A; Fraser P; Cohen JI; de Saint Basile G; Alexander I; Wintergerst U; Frebourg T; Aurias A; Stoppa-Lyonnet D; Romana S; Radford-Weiss I; Gross F; Valensi F; Delabesse E; Macintyre E; Sigaux F; Soulier J; Leiva LE; Wissler M; Prinz C; Rabbitts TH; Le Deist F; Fischer A; Cavazzana-Calvo M
Science; 2003 Oct; 302(5644):415-9. PubMed ID: 14564000
[TBL] [Abstract][Full Text] [Related]
49. Intracellular trafficking of retroviral genomes during the early phase of infection: viral exploitation of cellular pathways.
Goff SP
J Gene Med; 2001; 3(6):517-28. PubMed ID: 11778899
[TBL] [Abstract][Full Text] [Related]
50. Retroviral DNA integration: HIV and the role of LEDGF/p75.
Ciuffi A; Bushman FD
Trends Genet; 2006 Jul; 22(7):388-95. PubMed ID: 16730094
[TBL] [Abstract][Full Text] [Related]
51. Strategies for retrovirus-based correction of severe, combined immunodeficiency (SCID).
Fischer A; Hacein-Bey-Abina S; Cavazzana-Calvo M
Methods Enzymol; 2012; 507():15-27. PubMed ID: 22365767
[TBL] [Abstract][Full Text] [Related]
52. Identification of a high incidence region for retroviral vector integration near exon 1 of the LMO2 locus.
Yamada K; Tsukahara T; Yoshino K; Kojima K; Agawa H; Yamashita Y; Amano Y; Hatta M; Matsuzaki Y; Kurotori N; Wakui K; Fukushima Y; Osada R; Shiozawa T; Sakashita K; Koike K; Kumaki S; Tanaka N; Takeshita T
Retrovirology; 2009 Sep; 6():79. PubMed ID: 19725963
[TBL] [Abstract][Full Text] [Related]
53. Deciphering the code for retroviral integration target site selection.
Santoni FA; Hartley O; Luban J
PLoS Comput Biol; 2010 Nov; 6(11):e1001008. PubMed ID: 21124862
[TBL] [Abstract][Full Text] [Related]
54. Radiation leukemia virus common integration at the Kis2 locus: simultaneous overexpression of a novel noncoding RNA and of the proximal Phf6 gene.
Landais S; Quantin R; Rassart E
J Virol; 2005 Sep; 79(17):11443-56. PubMed ID: 16103195
[TBL] [Abstract][Full Text] [Related]
55. Overview of the retrovirus transduction system.
Cepko C; Pear W
Curr Protoc Mol Biol; 2001 May; Chapter 9():Unit9.9. PubMed ID: 18265289
[TBL] [Abstract][Full Text] [Related]
56. [Clonal expansion and genomic characterization of the human T-cell lymphotropic virus type I during the integration process in adult T-cell leukemia/lymphoma].
Salcedo-Cifuentes M; Cabrera J; Cuesta-Astroz Y; Carrasca E; Eizuru Y; Domínguez MC; Sánchez A; García-Vallejo F
Biomedica; 2009 Jun; 29(2):218-31. PubMed ID: 20128347
[TBL] [Abstract][Full Text] [Related]
57. Specific insertions of zinc finger domains into Gag-Pol yield engineered retroviral vectors with selective integration properties.
Lim KI; Klimczak R; Yu JH; Schaffer DV
Proc Natl Acad Sci U S A; 2010 Jul; 107(28):12475-80. PubMed ID: 20616052
[TBL] [Abstract][Full Text] [Related]
58. Expression and biological significance of human endogenous retroviral sequences.
Leib-Mösch C; Bachmann M; Brack-Werner R; Werner T; Erfle V; Hehlmann R
Leukemia; 1992; 6 Suppl 3():72S-75S. PubMed ID: 1602831
[TBL] [Abstract][Full Text] [Related]
59. Targeting survival: integration site selection by retroviruses and LTR-retrotransposons.
Bushman FD
Cell; 2003 Oct; 115(2):135-8. PubMed ID: 14567911
[TBL] [Abstract][Full Text] [Related]
60. A high-throughput method for cloning and sequencing human immunodeficiency virus type 1 integration sites.
Kim S; Kim Y; Liang T; Sinsheimer JS; Chow SA
J Virol; 2006 Nov; 80(22):11313-21. PubMed ID: 16971446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
